
Annual report 2025
added 02-24-2026
Alphatec Holdings EPS Ratio 2011-2026 | ATEC
EPS is a measure used to assess the financial stability and profitability of a company. EPS (Earnings Per Share) represents the company's net income divided by the number of its outstanding shares. This measure allows investors and analysts to evaluate the return on investment in the company's stock and compare it to other companies in the industry.
The term earnings per share (EPS) represents the portion of a company's earnings, net of taxes and preferred stock dividends, that is allocated to each share of common stock. The figure can be calculated simply by dividing net income earned in a given reporting period (usually quarterly or annually) by the total number of shares outstanding during the same term. Because the number of shares outstanding can fluctuate, a weighted average is typically used.
Calculated as:
EPS = (Net Income - Dividends on Preffered Stock) / Average Outstanding shares[1]
EPS can be calculated as a simple ratio of net income to shares, or in various variations, such as diluted EPS, which takes into account the potential issuance of new shares or convertible securities.
A high EPS ratio usually indicates that the company has good profitability and efficiency in utilizing its assets. However, other factors such as sales growth, debt burden, and the company's competitive position should also be considered.
EPS ratio is an important indicator for investors when making decisions to buy or sell a company's stock. It is also used by analysts to assess the financial condition of the company and its potential for growth and development.
Annual EPS Ratio Alphatec Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.96 | -1.13 | -1.54 | -1.46 | -1.49 | -1.18 | -1.09 | -1.2 | -0.18 | -3.49 | -1.79 | -0.13 | -0.85 | -0.17 | -0.25 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.13 | -3.49 | -1.13 |
Quarterly EPS Ratio Alphatec Holdings
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.27 | -0.35 | - | -0.28 | -0.29 | -0.34 | - | -0.35 | -0.43 | -0.4 | - | -0.35 | -0.36 | -0.43 | - | -0.43 | -0.39 | -0.26 | - | -0.24 | -0.25 | -0.33 | - | -0.26 | -0.27 | -0.29 | - | -0.22 | -0.21 | -0.09 | - | -0.23 | -0.24 | -0.61 | -0.49 | -1.6 | -0.05 | -0.07 | -0.1 | -1.61 | -0.04 | -0.05 | - | -0.03 | -0.03 | -0.07 | -0.62 | -0.15 | -0.05 | -0.03 | -0.06 | -0.03 | -0.07 | -0.01 | -0.18 | -0.01 | -0.03 | -0.02 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -0.01 | -1.61 | -0.277 |
References
- Khan, T. R., Islam, M. R., Choudhury, T. T., & Adnan, A. M. (2014). How earning per share (EPS) affects on share price and firm value.
EPS Ratio of other stocks in the Medical devices industry
| Issuer | EPS Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acutus Medical
AFIB
|
-2.81 | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
-0.48 | - | 3.58 % | $ 2.21 M | ||
|
ClearPoint Neuro
CLPT
|
-0.7 | $ 14.09 | -7.06 % | $ 381 M | ||
|
Apollo Endosurgery
APEN
|
-0.98 | - | - | $ 475 M | ||
|
Avinger
AVGR
|
-23.3 | - | -20.74 % | $ 369 K | ||
|
AxoGen
AXGN
|
-0.34 | $ 31.87 | 2.07 % | $ 1.47 B | ||
|
Cognyte Software Ltd.
CGNT
|
-0.17 | $ 7.0 | 5.74 % | $ 503 M | ||
|
EDAP TMS S.A.
EDAP
|
-0.51 | $ 4.38 | -4.58 % | $ 163 M | ||
|
Axonics Modulation Technologies
AXNX
|
-1.28 | - | - | $ 3.31 B | ||
|
Electromed
ELMD
|
0.89 | $ 24.18 | 1.09 % | $ 204 M | ||
|
Aziyo Biologics
AZYO
|
-2.07 | - | 1.37 % | $ 20.5 M | ||
|
Apyx Medical Corporation
APYX
|
-0.54 | $ 3.49 | 2.05 % | $ 121 M | ||
|
Conformis
CFMS
|
-6.99 | - | - | $ 16.4 M | ||
|
Bio-Rad Laboratories
BIO
|
-25.6 | $ 275.33 | 2.19 % | $ 7.77 B | ||
|
BIOLASE
BIOL
|
-29.4 | - | -13.19 % | $ 166 K | ||
|
Bruker Corporation
BRKR
|
0.76 | $ 40.88 | 2.48 % | $ 6.09 K | ||
|
BioSig Technologies
BSGM
|
-0.75 | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
1.96 | $ 75.65 | 2.97 % | $ 112 B | ||
|
InMode Ltd.
INMD
|
1.45 | $ 14.0 | 0.29 % | $ 905 M | ||
|
IRIDEX Corporation
IRIX
|
-0.59 | $ 1.47 | -2.0 % | $ 23.7 M | ||
|
IRadimed Corporation
IRMD
|
1.52 | $ 102.4 | 1.89 % | $ 1.3 B | ||
|
CONMED Corporation
CNMD
|
1.52 | $ 45.89 | -0.18 % | $ 1.42 B | ||
|
Cardiovascular Systems
CSII
|
-0.94 | - | 0.15 % | $ 844 M | ||
|
LivaNova PLC
LIVN
|
-4.45 | $ 71.26 | 1.38 % | $ 3.89 B | ||
|
Cutera
CUTR
|
-2.87 | - | -10.19 % | $ 1.99 M | ||
|
Medtronic PLC
MDT
|
3.63 | $ 97.22 | 0.58 % | $ 125 B | ||
|
Delcath Systems
DCTH
|
-0.93 | $ 9.11 | -10.77 % | $ 260 M | ||
|
Nano-X Imaging Ltd.
NNOX
|
-0.91 | $ 2.48 | 1.02 % | $ 146 M | ||
|
Dynatronics Corporation
DYNT
|
-1.43 | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
-39.7 | - | - | $ 10.2 M | ||
|
Second Sight Medical Products
EYES
|
-0.43 | - | -0.97 % | $ 54.4 M | ||
|
Establishment Labs Holdings
ESTA
|
-3 | $ 77.41 | -1.12 % | $ 2.18 B | ||
|
Insulet Corporation
PODD
|
3.51 | $ 251.74 | 1.46 % | $ 17.7 B | ||
|
Quanterix Corporation
QTRX
|
-0.86 | $ 6.7 | 6.52 % | $ 252 M | ||
|
GBS
GBS
|
-2 | - | -0.57 % | $ 7.12 M | ||
|
FONAR Corporation
FONR
|
1.78 | $ 18.53 | -0.3 % | $ 121 M | ||
|
Sintx Technologies
SINT
|
-2.22 | $ 2.89 | -1.87 % | $ 10.8 M | ||
|
MiMedx Group
MDXG
|
0.33 | $ 4.97 | -5.78 % | $ 735 M |